Pharmacokinetics and bioequivalence evaluation of two oral formulations of cotrimoxazole tablets in healthy Chinese volunteers under fasting conditions.

"Declarations Ethics approval and consent to participateThe study protocol and informed consent documents were approved by the Ethics Committee of Xinxiang central hospital (2018-044). Written informed consent was obtained from all participates. The trial was conducted following the Declaration of Helsinki, Good clinical practice (GCP) and the guidelines of China National Medical Products Administration (NMPA). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was partly supported by Henan Province Medical Science and Technology Tackling Program Joint Co-Construction Project (No. LHGJ20191332 and LHGJ 20230881)."